>

Investor Information

February, 2018: The USPTO announced that the BLOS# patent application will be allowed and a patent issued in the coming weeks.

July 11, 2017: The USPTO announced that the CAT-FISH method will be an issued patent on July 25, 2017.  CAT-FISH is an example of another molecular biology based method co-invented and published in a peer-reviewed journal by Dr. Peter Stroot.  The RiboSyn method is another example of a novel molecular biology based method that was published and patented.

HemaGnosis is offering an opportunity for companies to participate in forthcoming clinical trials.  Call John Kimber (720) 355-0446 for details. 


March 16, 2017: HemaGnosis has been invited to attend the 2017 BioBoot Camp Program April 20-21 in Denver, CO. 


2016 Annual Report Available

>>> Link to 2016 Annual Report<<<


Pitch Deck

HemaGnosis is currently seeking an investment of $3M to complete a clinical trial in Australia for the LifeStyle Choice BLOS# method.  A Pitch Deck is provided below.


Formula
 

 
Formula

Formula

Formula

Formula

Formula

Formula

Formula

Formula

Formula

Formula

Formula

Formula

Formula


PASTE RESPONSIVE AD